The Safety and Tolerability of Atopaxar (E5555) in ... - summitMD.com
The Safety and Tolerability of Atopaxar (E5555) in ... - summitMD.com
The Safety and Tolerability of Atopaxar (E5555) in ... - summitMD.com
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
LANCELOT-ACS<br />
PDF-XChange Viewer<br />
w w w.docu-track.co m<br />
Click to buy NOW!<br />
Key Secondary Objectives<br />
PDF-XChange Viewer<br />
w w w.docu-track.co m<br />
Click to buy NOW!<br />
• To determ<strong>in</strong>e the effects <strong>of</strong> atopaxar on the <strong>in</strong>cidence <strong>of</strong><br />
major adverse cardiac events (MACE), <strong>in</strong>clud<strong>in</strong>g CV<br />
death, myocardial <strong>in</strong>farction (MI), stroke, or recurrent<br />
ischemia<br />
• To determ<strong>in</strong>e the effect <strong>of</strong> atopaxar on the <strong>in</strong>cidence <strong>of</strong><br />
transient ischemia by cont<strong>in</strong>uous ECG (Holter)<br />
• To determ<strong>in</strong>e the effect <strong>of</strong> atopaxar on platelet<br />
aggregation (at selected sites)
Change language